The global wound irrigation system market is expected to reach US$ 310.43 Mn in 2027 from US$ 238.43 Mn in 2018.
Wound irrigation system market is growing at significant rate due to presence of countable number of players, having considerable revenue in the market. Most of the companies operating in the wound irrigation system market offer battery operated and manually operated wound irrigation systems for chronic and acute wounds. The wound irrigation systems are used for hydrating open wound surface by removing deeper debris for better visualization of wound. In this wound irrigation solutions are incorporated by battery or manually operated wound irrigation system.
The most notable Wound irrigation system market participants are Bionix Development Corporation, BSN Medical, C.R. Bard, Inc. CooperSurgical, Inc , Stryker Corporation, Zimmer Biomet, SunMed, Centurion Medical Products among the others have occupied a considerable share of the market owing to their product offerings to the market.
Market leaders are involved in organic and inorganic growth strategies in the wound irrigation system market. For instance, the companies have maximized their growth with several organic strategies to enhance the market value and position in the market. The organic developments in the market were maximum among the development in the wound irrigation system.
The market has experienced several organic strategies such as product launch, business expansion, and relocation activities that has resulted positively for the growth of the market. These strategies have helped players and markets to strengthen their product portfolio.
The inorganic and organic strategies done by the players operating in the wound irrigation system market, For instance, in February 2017, Centurion launched IRIG-8 system, a new irrigation system for wound management. The system is sterile and disposable and is being used for quick delivery of solution being used for irrigation, with customizable, constant, and adequate pressure. The newly introduced product is being used as a substitute for traditional syringes with splash caps. One of the acquisition of C.R Bard by BD in December 2017 has led the company to hold one of the dominant shares across the entire healthcare segment, since the C.R Bard has a strong product offering across various business offerings.